"We have to be very careful because asset prices are very expensive. By having a very disciplined M&A policy, we managed to improve our return on invested capital over the last four years," he said, noting Horlicks would have been a great fit but cost too much.

Unilever snapped up GlaxoSmithKline Horlicks nutrition business for $3.8 billion.

"We didn't necessarily want to make a big entry in coffee shops, but it made sense for us to do a test in the super premium area with Blue Bottle. (...) It is interesting for us to understand what is going on in that space that is more about service while we focus more on products."

(Reporting by Silke Koltrowitz, Editing by Michael Shields)